Abatacept
The risk or severity of adverse effects can be increased when Rituximab is combined with Abatacept.
Acebutolol
Acebutolol may increase the hypotensive activities of Rituximab.
Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Rituximab.
Advertisement
Adalimumab
The risk or severity of adverse effects can be increased when Adalimumab is combined with Rituximab.
Aliskiren
Aliskiren may increase the hypotensive activities of Rituximab.
Alprenolol
Alprenolol may increase the hypotensive activities of Rituximab.
Advertisement
Ambrisentan
Ambrisentan may increase the hypotensive activities of Rituximab.
Amlodipine
Amlodipine may increase the hypotensive activities of Rituximab.
Anakinra
The risk or severity of adverse effects can be increased when Anakinra is combined with Rituximab.
Advertisement
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Rituximab.
Anhydrous Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Rituximab.
Anthrax immune globulin, human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Rituximab.
Atenolol
Atenolol may increase the hypotensive activities of Rituximab.
BCG Vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Rituximab.
BCG, Live, Connaught Strain
The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Rituximab.
BCG, Live, Tice Strain
The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Rituximab.
Belimumab
The risk or severity of adverse effects can be increased when Rituximab is combined with Belimumab.
Benazepril
Benazepril may increase the hypotensive activities of Rituximab.
Bendroflumethiazide
Bendroflumethiazide may increase the hypotensive activities of Rituximab.
Bepridil
Bepridil may increase the hypotensive activities of Rituximab.
Betaxolol
Betaxolol may increase the hypotensive activities of Rituximab.
Bethanidine
Bethanidine may increase the hypotensive activities of Rituximab.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Rituximab.
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Rituximab.
Bimatoprost
Bimatoprost may increase the hypotensive activities of Rituximab.
Bisoprolol
Bisoprolol may increase the hypotensive activities of Rituximab.
Bosentan
Bosentan may increase the hypotensive activities of Rituximab.
Bretylium
Bretylium may increase the hypotensive activities of Rituximab.
Brimonidine
Brimonidine may increase the hypotensive activities of Rituximab.
Bupranolol
Bupranolol may increase the hypotensive activities of Rituximab.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Rituximab.
Cafedrine
Cafedrine may increase the hypotensive activities of Rituximab.
Candesartan
Candesartan may increase the hypotensive activities of Rituximab.
Candesartan Cilexetil
Candesartan cilexetil may increase the hypotensive activities of Rituximab.
Captopril
Captopril may increase the hypotensive activities of Rituximab.
Carteolol
Carteolol may increase the hypotensive activities of Rituximab.
Carvedilol
Carvedilol may increase the hypotensive activities of Rituximab.
Celiprolol
Celiprolol may increase the hypotensive activities of Rituximab.
Certolizumab Pegol
Rituximab may increase the immunosuppressive activities of Certolizumab pegol.
Chlorothiazide
Chlorothiazide may increase the hypotensive activities of Rituximab.
Chlorthalidone
Chlorthalidone may increase the hypotensive activities of Rituximab.
Cicletanine
Cicletanine may increase the hypotensive activities of Rituximab.
Cilazapril
Cilazapril may increase the hypotensive activities of Rituximab.
Clonidine
Clonidine may increase the hypotensive activities of Rituximab.
Clozapine
The risk or severity of adverse effects can be increased when Rituximab is combined with Clozapine.
Cryptenamine
Cryptenamine may increase the hypotensive activities of Rituximab.
Cyclopenthiazide
Cyclopenthiazide may increase the hypotensive activities of Rituximab.
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Rituximab.
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Rituximab.
Cyclothiazide
Cyclothiazide may increase the hypotensive activities of Rituximab.
Debrisoquin
Debrisoquin may increase the hypotensive activities of Rituximab.
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Rituximab.
Deserpidine
Deserpidine may increase the hypotensive activities of Rituximab.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Rituximab.
Diazoxide
Diazoxide may increase the hypotensive activities of Rituximab.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Rituximab.
Digoxin
Digoxin may decrease the cardiotoxic activities of Rituximab.
Dihydralazine
Dihydralazine may increase the hypotensive activities of Rituximab.
Diltiazem
Diltiazem may increase the hypotensive activities of Rituximab.
Dipyrone
The risk or severity of myelosuppression can be increased when Metamizole is combined with Rituximab.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Rituximab.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Rituximab.
Dorzolamide
Dorzolamide may increase the hypotensive activities of Rituximab.
Doxazosin
Doxazosin may increase the hypotensive activities of Rituximab.
Enalapril
Enalapril may increase the hypotensive activities of Rituximab.
Enalaprilat
Enalaprilat may increase the hypotensive activities of Rituximab.
Enalaprilat Anhydrous
Enalaprilat may increase the hypotensive activities of Rituximab.
Epoprostenol
Epoprostenol may increase the hypotensive activities of Rituximab.
Eprosartan
Eprosartan may increase the hypotensive activities of Rituximab.
Etanercept
The risk or severity of adverse effects can be increased when Etanercept is combined with Rituximab.
Felodipine
Felodipine may increase the hypotensive activities of Rituximab.
Fenoldopam
Fenoldopam may increase the hypotensive activities of Rituximab.
Ferulic Acid
Ferulic acid may increase the hypotensive activities of Rituximab.
Fingolimod
Rituximab may increase the immunosuppressive activities of Fingolimod.
Fosinopril
Fosinopril may increase the hypotensive activities of Rituximab.
Golimumab
The risk or severity of adverse effects can be increased when Golimumab is combined with Rituximab.
Guanabenz
Guanabenz may increase the hypotensive activities of Rituximab.
Guanadrel
Guanadrel may increase the hypotensive activities of Rituximab.
Guanethidine
Guanethidine may increase the hypotensive activities of Rituximab.
Guanfacine
Guanfacine may increase the hypotensive activities of Rituximab.
Hepatitis A Vaccine, Inactivated
The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Rituximab.
Hepatitis B Surface Antigen Vaccine
The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Rituximab.
Hydralazine
Hydralazine may increase the hypotensive activities of Rituximab.
Hydrochlorothiazide
Hydrochlorothiazide may increase the hypotensive activities of Rituximab.
Hydroflumethiazide
Hydroflumethiazide may increase the hypotensive activities of Rituximab.
Imidapril
Imidapril may increase the hypotensive activities of Rituximab.
Indapamide
Indapamide may increase the hypotensive activities of Rituximab.
Indoramin
Indoramin may increase the hypotensive activities of Rituximab.
Infliximab
The risk or severity of adverse effects can be increased when Infliximab is combined with Rituximab.
Infliximab-Abda
The risk or severity of adverse effects can be increased when Infliximab is combined with Rituximab.
Infliximab-Dyyb
The risk or severity of adverse effects can be increased when Infliximab is combined with Rituximab.
Irbesartan
Irbesartan may increase the hypotensive activities of Rituximab.
Isradipine
Isradipine may increase the hypotensive activities of Rituximab.
Ketanserin
Ketanserin may increase the hypotensive activities of Rituximab.
Labetalol
Labetalol may increase the hypotensive activities of Rituximab.
Lacidipine
Lacidipine may increase the hypotensive activities of Rituximab.
Latanoprost
Latanoprost may increase the hypotensive activities of Rituximab.
Leflunomide
The risk or severity of adverse effects can be increased when Rituximab is combined with Leflunomide.
Lercanidipine
Lercanidipine may increase the hypotensive activities of Rituximab.
Lisinopril
Lisinopril may increase the hypotensive activities of Rituximab.
Lisinopril Anhydrous
Lisinopril may increase the hypotensive activities of Rituximab.
Lofexidine
Lofexidine may increase the hypotensive activities of Rituximab.
Losartan
Losartan may increase the hypotensive activities of Rituximab.
Macitentan
Macitentan may increase the hypotensive activities of Rituximab.
Manidipine
Manidipine may increase the hypotensive activities of Rituximab.
Mecamylamine
Mecamylamine may increase the hypotensive activities of Rituximab.
Methyldopa
Methyldopa may increase the hypotensive activities of Rituximab.
METHYLDOPA ANHYDROUS
Methyldopa may increase the hypotensive activities of Rituximab.
Metipranolol
Metipranolol may increase the hypotensive activities of Rituximab.
Metolazone
Metolazone may increase the hypotensive activities of Rituximab.
Metoprolol
Metoprolol may increase the hypotensive activities of Rituximab.
Metyrosine
Metyrosine may increase the hypotensive activities of Rituximab.
Mibefradil
Mibefradil may increase the hypotensive activities of Rituximab.
Minoxidil
Minoxidil may increase the hypotensive activities of Rituximab.
Moexipril
Moexipril may increase the hypotensive activities of Rituximab.
Moxonidine
Moxonidine may increase the hypotensive activities of Rituximab.
Nadolol
Nadolol may increase the hypotensive activities of Rituximab.
Natalizumab
The risk or severity of adverse effects can be increased when Rituximab is combined with Natalizumab.
Nebivolol
Nebivolol may increase the hypotensive activities of Rituximab.
Nicardipine
Nicardipine may increase the hypotensive activities of Rituximab.
Nicorandil
Nicorandil may increase the hypotensive activities of Rituximab.
Nilvadipine
Nilvadipine may increase the hypotensive activities of Rituximab.
Nimodipine
Nimodipine may increase the hypotensive activities of Rituximab.
Nisoldipine
Nisoldipine may increase the hypotensive activities of Rituximab.
Nitrendipine
Nitrendipine may increase the hypotensive activities of Rituximab.
Nitroprusside
Nitroprusside may increase the hypotensive activities of Rituximab.
Ocrelizumab
Ocrelizumab may increase the immunosuppressive activities of Rituximab.
Olmesartan
Olmesartan may increase the hypotensive activities of Rituximab.
Ouabain
Ouabain may decrease the cardiotoxic activities of Rituximab.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Rituximab.
Oxprenolol
Oxprenolol may increase the hypotensive activities of Rituximab.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Rituximab.
Pargyline
Pargyline may increase the hypotensive activities of Rituximab.
Penbutolol
Penbutolol may increase the hypotensive activities of Rituximab.
Perindopril
Perindopril may increase the hypotensive activities of Rituximab.
Phenoxybenzamine
Phenoxybenzamine may increase the hypotensive activities of Rituximab.
Phentolamine
Phentolamine may increase the hypotensive activities of Rituximab.
Phentolamine Mesylate
Phentolamine may increase the hypotensive activities of Rituximab.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Rituximab.
Pinacidil
Pinacidil may increase the hypotensive activities of Rituximab.
Pindolol
Pindolol may increase the hypotensive activities of Rituximab.
Polythiazide
Polythiazide may increase the hypotensive activities of Rituximab.
Prazosin
Prazosin may increase the hypotensive activities of Rituximab.
Propranolol
Propranolol may increase the hypotensive activities of Rituximab.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Rituximab.
Quinapril
Quinapril may increase the hypotensive activities of Rituximab.
Rabies Immune Globulin, Human
The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Rituximab.
Rabies Virus Vaccine Flury-Lep Strain
The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Rituximab.
Ramipril
Ramipril may increase the hypotensive activities of Rituximab.
Rescinnamine
Rescinnamine may increase the hypotensive activities of Rituximab.
Reserpine
Reserpine may increase the hypotensive activities of Rituximab.
Rilmenidine
Rilmenidine may increase the hypotensive activities of Rituximab.
Riociguat
Riociguat may increase the hypotensive activities of Rituximab.
Roflumilast
Roflumilast may increase the immunosuppressive activities of Rituximab.
ROTAVIRUS VACCINE, LIVE
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Rituximab.
Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)
The therapeutic efficacy of Rubella virus vaccine can be decreased when used in combination with Rituximab.
Salmonella enterica subsp. enterica serovar typhi
The therapeutic efficacy of Salmonella typhi ty21a live antigen can be decreased when used in combination with Rituximab.
Sarilumab
Sarilumab may increase the immunosuppressive activities of Rituximab.
Selexipag
Selexipag may increase the hypotensive activities of Rituximab.
sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Rituximab.
Spirapril
Spirapril may increase the hypotensive activities of Rituximab.
Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Rituximab.
Talinolol
Talinolol may increase the hypotensive activities of Rituximab.
Telmisartan
Telmisartan may increase the hypotensive activities of Rituximab.
Terlipressin
Terlipressin may increase the hypotensive activities of Rituximab.
Tetanus Toxoid Vaccine, Inactivated
The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Rituximab.
Theodrenaline
Theodrenaline may increase the hypotensive activities of Rituximab.
Tibolone
Tibolone may increase the hypotensive activities of Rituximab.
Timolol
Timolol may increase the hypotensive activities of Rituximab.
Timolol Anhydrous
Timolol may increase the hypotensive activities of Rituximab.
Tocilizumab
The risk or severity of adverse effects can be increased when Rituximab is combined with Tocilizumab.
Tofacitinib
The risk or severity of adverse effects can be increased when Rituximab is combined with Tofacitinib.
Tolazoline
Tolazoline may increase the hypotensive activities of Rituximab.
Torsemide
Torasemide may increase the hypotensive activities of Rituximab.
Trandolapril
Trandolapril may increase the hypotensive activities of Rituximab.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Rituximab.
Travoprost
Travoprost may increase the hypotensive activities of Rituximab.
Treprostinil
Treprostinil may increase the hypotensive activities of Rituximab.
Trichlormethiazide
Trichlormethiazide may increase the hypotensive activities of Rituximab.
Trimethaphan
Trimethaphan may increase the hypotensive activities of Rituximab.
Typhoid Vaccine Live Ty21a
The therapeutic efficacy of Salmonella typhi ty21a live antigen can be decreased when used in combination with Rituximab.
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
The therapeutic efficacy of Salmonella typhi ty2 vi polysaccharide antigen can be decreased when used in combination with Rituximab.
UNOPROSTONE
Unoprostone may increase the hypotensive activities of Rituximab.
Urapidil
Urapidil may increase the hypotensive activities of Rituximab.
Valsartan
Valsartan may increase the hypotensive activities of Rituximab.
Varicella Virus Vaccine Live (Oka-Merck) strain
The therapeutic efficacy of Varicella Zoster Vaccine (Live/Attenuated) can be decreased when used in combination with Rituximab.
Vincamine
Vincamine may increase the hypotensive activities of Rituximab.
Vinpocetine
Vinpocetine may increase the hypotensive activities of Rituximab.
Xylometazoline
Xylometazoline may increase the hypotensive activities of Rituximab.
Yellow Fever Vaccine
The therapeutic efficacy of Yellow Fever Vaccine can be decreased when used in combination with Rituximab.
Yellow-Fever Virus Vaccine, 17D-204 strain
The therapeutic efficacy of Yellow Fever Vaccine can be decreased when used in combination with Rituximab.
Zofenopril
Zofenopril may increase the hypotensive activities of Rituximab.
